Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer.
Breast-conserving surgery followed by radiotherapy is effective in reducing recurrence; however, telangiectasia and fibrosis can occur as late skin side effects. As radiotherapy acts through producing DNA damage, we investigated whether genetic variation in DNA repair and damage response confers increased susceptibility to develop late normal skin complications. Breast cancer patients who received radiotherapy after breast-conserving surgery were examined for late complications of radiotherapy after a median follow-up time of 51 months. Polymorphisms in genes involved in DNA repair (APEX1, XRCC1, XRCC2, XRCC3, XPD) and damage response (TP53, P21) were determined. Associations between telangiectasia and genotypes were assessed among 409 patients, using multivariate logistic regression. A total of 131 patients presented with telangiectasia and 28 patients with fibrosis. Patients with variant TP53 genotypes either for the Arg72Pro or the PIN3 polymorphism were at increased risk of telangiectasia. The odds ratios (OR) were 1.66 (95% confidence interval (CI): 1.02-2.72) for 72Pro carriers and 1.95 (95% CI: 1.13-3.35) for PIN3 A2 allele carriers compared with non-carriers. The TP53 haplotype containing both variant alleles was associated with almost a two-fold increase in risk (OR 1.97, 95% CI: 1.11-3.52) for telangiectasia. Variants in the TP53 gene may therefore modify the risk of late skin toxicity after radiotherapy.
Chang-Claude
J
J
Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. j.chang-claude@dkfz.de
Ambrosone
C B
CB
Lilla
C
C
Kropp
S
S
Helmbold
I
I
von Fournier
D
D
Haase
W
W
Sautter-Bihl
M-L
ML
Wenz
F
F
Schmezer
P
P
Popanda
O
O
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000235:genetics* / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy / Q000009:adverse effects; D004249:DNA Damage / Q000235:genetics* / Q000502:physiology; D004260:DNA Repair / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D016158:Genes, p53; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D015412:Mastectomy, Segmental / Q000534:rehabilitation; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000502:physiology; D020641:Polymorphism, Single Nucleotide; D011832:Radiation Injuries / Q000150:complications / Q000235:genetics* / Q000473:pathology; D012871:Skin Diseases / Q000209:etiology / Q000235:genetics